Mariner
TYRA icon

Mariner’s Tyra Biosciences TYRA Stock Holding History

Mariner’s Portfolio TYRA Stock Details TYRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-9,269
Closed -$218K – 3520
2024
Q3 		$218K Sell
9,269
-1,516
-14% -$31.8K ﹤0.01% 2870
2024
Q2 		$172K Buy
+10,785
New +$186K ﹤0.01% 2828
2024
Q1 		– Sell
-22,164
Closed -$307K – 3241
2023
Q4 		$307K Sell
22,164
-2,132
-9% -$27.6K ﹤0.01% 2329
2023
Q3 		$335K Buy
24,296
+2,723
+13% +$40.4K ﹤0.01% 2062
2023
Q2 		$367K Buy
21,573
+44
+0.2% +$638 ﹤0.01% 1967
2023
Q1 		$346K Buy
+21,529
New +$256K ﹤0.01% 1957

Other funds holding TYRA

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
CPX
Canaan Partners XI Menlo Park, California $76.1M AUM 638.59% 1-Year Est. Return
APMC
Alta Partners Management Company Jackson, Wyoming $151M AUM 296.21% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $762M AUM 1,125.36% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Mariner's TYRA Position: Q4 2024 in Review

Mariner sold out of Tyra Biosciences (TYRA) in Q4 2024, closing a stake of 9,269 shares — an estimated $218K sold.

Mariner first reported a position in TYRA in Q1 2023 and held it in 6 quarters. The position peaked at $367K in Q2 2023. 113 funds tracked by Wall St. Rank hold TYRA as of Q4 2024.

  • Mariner reported no remaining Tyra Biosciences position as of Q4 2024 after selling out during the quarter.
  • Mariner sold 9,269 Tyra Biosciences shares in Q4 2024, an estimated $218K.
  • Mariner first reported a position in Tyra Biosciences in Q1 2023 and held it in 6 quarters.
  • Mariner's Tyra Biosciences position peaked at $367K in Q2 2023.
  • 113 funds tracked by Wall St. Rank held Tyra Biosciences as of Q4 2024.

Based on Mariner's 13F filing for Q4 2024, filed 13 Feb 2025.